Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 9 Lymphoma, Non-Hodgkin 9 Lymphoma, B-Cell 5 Arthritis, Rheumatoid 5 Solid Tumors 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma 4 Carcinoma, Non-Small-Cell Lung 4 Recurrence 3 Colorectal Neoplasms 3 Ovarian Neoplasms 2 Lymphoma, Follicular 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Fallopian Tube Neoplasms 2 Breast Neoplasms 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Spondylitis, Ankylosing 1 Small Cell Lung Carcinoma 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 Mesothelioma 1 Melanoma 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Kidney Neoplasms 1 Esophageal Neoplasms 1

Interventions

tocilizumab 1 atezolizumab 1 Tiragolumab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Advanced Liver Cancers × tocilizumab × Clear all

NCT04524871 2026-05-22

MORPHEUS-LIVER

Hoffmann-La Roche

Phase 1/2 Recruiting

Advanced Liver Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡